Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 1751–1800 of 33040
Althea Brown submitted her resignation as the Chief Legal Officer and Corporate Secretary of LPL Financial Holdings Inc. (the “Company”) effective June 30, 2025, when she will depart the Company.
On May 30, 2025, Nanci Gilmore, the Chief Commercial Officer of Sanuwave Health, Inc. (the “Company”), was terminated without cause, effective as of the same date.
On June 2, 2025, Todd E. Telesz , our Senior Vice President and Chief Financial Officer, informed us that he intends to resign from us on June 13, 2025, to take a position as the Chief Financial Officer for a vertically integrated independent power producer headquartered in Colorado.
On the Effective Date, Mr. Lawless will succeed Craig Shore, whose employment as the Company’s Chief Financial Officer will be terminated simultaneous with Mr. Lawless’s appointment.
On May 30, 2025, Rick Parod resigned from the Board of Directors (the “Board”) of Dragonfly Energy Holdings Corp. (the “Company”), effective May 31, 2025.
Ms. Lori L. Colvin, Vice President/Controller/Chief Accounting Officer for the Companies, informed the Companies of her intention to retire effective June 1, 2025.
Mr. Horowitz subsequently notified the Company on June 3, 2025 (the “Effective Date”) of his resignation, effective immediately, from the Company’s Board of Directors (the “Board”).
On May 28, 2025, Patrick Walters notified the Board of Directors of NeOnc Technologies Holdings, Inc. (the “Company”) of his decision to retire as Chief Operating Officer of the Company effective June 1, 2025.
As previously disclosed, on May 16, 2025, Brian J. Gyomory, the Executive Vice President and Chief Financial Officer of 1st Franklin Financial Corporation (the "Company"), informed the Company of his intent to retire from the Company, effective May 31, 2025.
On May 27, 2025, Lori Robinson resigned from the Board of Directors of NACCO Industries, Inc. (the “Company”), effective immediately.
FLIC’s directors and executive officers ceased serving as directors and executive officers of FLIC. In addition, as of the Effective Time and in accordance with the Merger Agreement, the following individuals, each of whom was a member of the board of directors of FLIC immediately prior to consummation of the Merger, were appointed to the board of directors of ConnectOne: Christopher Becker, Edward J. Haye and Peter Quick.
FLIC’s directors and executive officers ceased serving as directors and executive officers of FLIC. In addition, as of the Effective Time and in accordance with the Merger Agreement, the following individuals, each of whom was a member of the board of directors of FLIC immediately prior to consummation of the Merger, were appointed to the board of directors of ConnectOne: Christopher Becker, Edward J. Haye and Peter Quick.
FLIC’s directors and executive officers ceased serving as directors and executive officers of FLIC. In addition, as of the Effective Time and in accordance with the Merger Agreement, the following individuals, each of whom was a member of the board of directors of FLIC immediately prior to consummation of the Merger, were appointed to the board of directors of ConnectOne: Christopher Becker, Edward J. Haye and Peter Quick.
On May 31, 2025, Marques Coleman, who currently serves as a Class II director on the Board of Directors (the “Board”) of ADT Inc. (the “Company”) with a term expiring at the Company’s 2028 Annual Meeting of Stockholders, retired from his position as a member of the Board.
On May 28, 2025, Keith Stauffer notified the Company of his decision to resign as the Company’s Chief Financial Officer (“CFO”), effective July 18, 2025
As previously announced, George E. Kilguss III, Executive Vice President and Chief Financial Officer of VeriSign, Inc. (the “Company”), retired from the Company effective May 31, 2025.
On the Effective Date, the Company and Daniel Szot, the Company’s Chief Revenue Officer, mutually agreed to Mr. Szot’s separation from the Company, to take effect at the end of the third fiscal quarter which allows for smooth transition as Mr. Szot seeks to pursue other opportunities.
On May 30, 2025, William H. Flores resigned as a member of the Board of Directors of New Era Helium, Inc. (the “ Company ”) with an effective date of May 30, 2025.
Jeffrey Blizard, a member of the Board of Directors (the “ Board ”) of TELA Bio, Inc. (the “ Company ”), tendered his resignation from the Board, effective as of June 2, 2025.
Stuart V. Flavin III, the Company’s Interim Chief Executive Officer and Interim President, agreed to transition out of these positions on the CEO Effective Date but will remain a member of the Board.
On May 30, 2025, Thomas Loewald informed the Company of his resignation from the board of directors (the “Board”) of Harvard Bioscience, Inc. (the “Company”), effective May 30, 2025.
Effective as of May 29, 2025, Kevin B. Reid, Sr. resigned as General Counsel and Corporate Secretary of the Company.
each of Mark Vachon, John O. Agwunobi, M.D., Mike Cloonan, Charlotte Jones-Burton, M.D., Lis Leiderman, M.D., Nick Leschly, Andrew Obenshain, Richard Paulson and Najoh Tita-Reid ceased to be members of the Board and ceased to be members of any committees of the Board on which such directors served, effective as of the Effective Time.
each of Mark Vachon, John O. Agwunobi, M.D., Mike Cloonan, Charlotte Jones-Burton, M.D., Lis Leiderman, M.D., Nick Leschly, Andrew Obenshain, Richard Paulson and Najoh Tita-Reid ceased to be members of the Board and ceased to be members of any committees of the Board on which such directors served, effective as of the Effective Time.
each of Mark Vachon, John O. Agwunobi, M.D., Mike Cloonan, Charlotte Jones-Burton, M.D., Lis Leiderman, M.D., Nick Leschly, Andrew Obenshain, Richard Paulson and Najoh Tita-Reid ceased to be members of the Board and ceased to be members of any committees of the Board on which such directors served, effective as of the Effective Time.
each of Mark Vachon, John O. Agwunobi, M.D., Mike Cloonan, Charlotte Jones-Burton, M.D., Lis Leiderman, M.D., Nick Leschly, Andrew Obenshain, Richard Paulson and Najoh Tita-Reid ceased to be members of the Board and ceased to be members of any committees of the Board on which such directors served, effective as of the Effective Time.
the employment of each of Messrs. Andrew Obenshain, Joseph Vittiglio, and O. James Sterling (the “Executives”) has terminated as of the Effective Time.
each of Mark Vachon, John O. Agwunobi, M.D., Mike Cloonan, Charlotte Jones-Burton, M.D., Lis Leiderman, M.D., Nick Leschly, Andrew Obenshain, Richard Paulson and Najoh Tita-Reid ceased to be members of the Board and ceased to be members of any committees of the Board on which such directors served, effective as of the Effective Time.
each of Mark Vachon, John O. Agwunobi, M.D., Mike Cloonan, Charlotte Jones-Burton, M.D., Lis Leiderman, M.D., Nick Leschly, Andrew Obenshain, Richard Paulson and Najoh Tita-Reid ceased to be members of the Board and ceased to be members of any committees of the Board on which such directors served, effective as of the Effective Time.
each of Mark Vachon, John O. Agwunobi, M.D., Mike Cloonan, Charlotte Jones-Burton, M.D., Lis Leiderman, M.D., Nick Leschly, Andrew Obenshain, Richard Paulson and Najoh Tita-Reid ceased to be members of the Board and ceased to be members of any committees of the Board on which such directors served, effective as of the Effective Time.
the employment of each of Messrs. Andrew Obenshain, Joseph Vittiglio, and O. James Sterling (the “Executives”) has terminated as of the Effective Time.
each of Mark Vachon, John O. Agwunobi, M.D., Mike Cloonan, Charlotte Jones-Burton, M.D., Lis Leiderman, M.D., Nick Leschly, Andrew Obenshain, Richard Paulson and Najoh Tita-Reid ceased to be members of the Board and ceased to be members of any committees of the Board on which such directors served, effective as of the Effective Time.
each of Mark Vachon, John O. Agwunobi, M.D., Mike Cloonan, Charlotte Jones-Burton, M.D., Lis Leiderman, M.D., Nick Leschly, Andrew Obenshain, Richard Paulson and Najoh Tita-Reid ceased to be members of the Board and ceased to be members of any committees of the Board on which such directors served, effective as of the Effective Time.
the employment of each of Messrs. Andrew Obenshain, Joseph Vittiglio, and O. James Sterling (the “Executives”) has terminated as of the Effective Time.
each of Fumihiro Kozato, Dr. Feng Kuo, Robert Cochran, Fun-Kai Liu, and Dr. Yaichi Aoshima ceased to serve on the board of directors
Fumihiro Kozato ceased to serve as the principal executive officer
Darron Ma ceased to serve as the principal operating officer
each of Fumihiro Kozato, Dr. Feng Kuo, Robert Cochran, Fun-Kai Liu, and Dr. Yaichi Aoshima ceased to serve on the board of directors
each of Fumihiro Kozato, Dr. Feng Kuo, Robert Cochran, Fun-Kai Liu, and Dr. Yaichi Aoshima ceased to serve on the board of directors
On May 30, 2025, Anthony M. Corriggio provided notice to Cohen & Steers Income Opportunities REIT, Inc. (the “Company”) of his decision to retire from his positions as President and Chief Operating Officer of the Company, after a 33-year career in the real estate industry.
Immediately prior to the Effective Time, each of the Executives resigned as officers of the Company, Brad Barber and John M. Engquist resigned from the board of directors of the Company
At the Effective Time, in accordance with the Merger Agreement, each of Paul N. Arnold, Gary W. Bagley, Bruce C. Bruckmann, Patrick L. Edsell, Thomas J. Galligan III, Lawrence C. Karlson, Jacob Thomas and Mary P. Thompson resigned from the board of directors of the Company.
Immediately prior to the Effective Time, each of the Executives resigned as officers of the Company, Brad Barber and John M. Engquist resigned from the board of directors of the Company
At the Effective Time, in accordance with the Merger Agreement, each of Paul N. Arnold, Gary W. Bagley, Bruce C. Bruckmann, Patrick L. Edsell, Thomas J. Galligan III, Lawrence C. Karlson, Jacob Thomas and Mary P. Thompson resigned from the board of directors of the Company.
Immediately prior to the Effective Time, each of the Executives resigned as officers of the Company, Brad Barber and John M. Engquist resigned from the board of directors of the Company
Immediately prior to the Effective Time, each of the Executives resigned as officers of the Company, Brad Barber and John M. Engquist resigned from the board of directors of the Company
At the Effective Time, in accordance with the Merger Agreement, each of Paul N. Arnold, Gary W. Bagley, Bruce C. Bruckmann, Patrick L. Edsell, Thomas J. Galligan III, Lawrence C. Karlson, Jacob Thomas and Mary P. Thompson resigned from the board of directors of the Company.
At the Effective Time, in accordance with the Merger Agreement, each of Paul N. Arnold, Gary W. Bagley, Bruce C. Bruckmann, Patrick L. Edsell, Thomas J. Galligan III, Lawrence C. Karlson, Jacob Thomas and Mary P. Thompson resigned from the board of directors of the Company.
At the Effective Time, in accordance with the Merger Agreement, each of Paul N. Arnold, Gary W. Bagley, Bruce C. Bruckmann, Patrick L. Edsell, Thomas J. Galligan III, Lawrence C. Karlson, Jacob Thomas and Mary P. Thompson resigned from the board of directors of the Company.
Immediately prior to the Effective Time, each of the Executives resigned as officers of the Company, Brad Barber and John M. Engquist resigned from the board of directors of the Company
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.